Publication Highlight: Activation of the IKK2/NF-κB pathway in VSMCs inhibits calcified vascular stiffness in Chronic Kidney Disease
Publication Highlight: Activation of the IKK2/NF-κB pathway in VSMCs inhibits calcified vascular stiffness
Scintica will be exhibiting at TERMIS Americas 2022. This year’s conference will be held at the Sheraton Centre Toronto Hotel in Toronto, Ontario.
Visit us at Booth 22!
Learn about our products like our IntraVital Microscopy and the NGB-R bioprinter. Enjoy a more hands-on approach to learning how these systems can help propel your research forward!
About the Meeting
TERMIS-AM is back with an exciting schedule to bring you the best education and networking you expect from a TERMIS conference! Our three internationally-renowned plenary speakers, fireside chat on commercialization, and 32 abstract-based sessions will show you the latest in TERM techniques and technology, all while taking advantage of the diversity and culture that Toronto offers in the summer months. Join us whether you’re a seasoned veteran or this is your first conference. Partake in a SYIS career panel, enjoy a beverage while perusing poster sessions, or visit a local lab during an offsite trip – we’ve got something for everyone! .
Scintica will be attending in person! Make sure to stop by and talk about how we can help you in person!
Who’s Attending?
Tissue Engineering and Regenerative Medicine International Society is hosting TERMIS Americas!
When does the Meeting Take Place?
Sunday, July 10 – Wednesday, July 13, 2022
Book your VR DEMO:
Publication Highlight: Activation of the IKK2/NF-κB pathway in VSMCs inhibits calcified vascular stiffness
Application Note: Bioprinting 3D Multi-cellular Cartilage Spheroids Using Laser-Assisted Technology View Paper Here
Publication Highlight: Single High-Dose Erythropoietin Disrupts Bone Homeostasis via Osteoclastogenic Pathways View Paper
Publication Highlight: Long-Term Optical Imaging Reveals Bone Marrow Clearance and Extramedullary Escape in
Publication Highlight: Overexpression of IL-32γ inhibits skin cancer formation through suppression of NF-κB
Publication Highlight: The role of phosphodiesterase 5 inhibitors in attenuating obesity-induced metabolic disorders